Genomic analysis of transcriptional networks directing progression of cell states during MGE development
Homeodomain (HD) transcription factor (TF) NKX2–1 critical for the regional specification of the medial ganglionic eminence (MGE) as well as promoting the GABAergic and cholinergic neuron fates via the induction of TFs such as LHX6 and LHX8. NKX2–1 defines MGE regional identity in large part through transcriptional repression, while specification and maturation of GABAergic and cholinergic fates is mediated in part by transcriptional activation via TFs such as LHX6 and LHX8. Here we analyze the signaling and TF pathways, downstream of NKX2–1, required for GABAergic and cholinergic neuron fate maturation.
Differential ChIP-seq analysis was used to identify regulatory elements (REs) where chromatin state was sensitive to change in the Nkx2–1cKO MGE at embryonic day (E) 13.5. TF motifs in the REs were identified using RSAT. CRISPR-mediated genome editing was used to generate enhancer knockouts. Differential gene expression in these knockouts was analyzed through RT-qPCR and in situ hybridization. Functional analysis of motifs within hs623 was analyzed via site directed mutagenesis and reporter assays in primary MGE cultures.
We identified 4782 activating REs (aREs) and 6391 repressing REs (rREs) in the Nkx2–1 conditional knockout (Nkx2–1cKO) MGE. aREs are associated with basic-Helix-Loop-Helix (bHLH) TFs. Deletion of hs623, an intragenic Tcf12 aRE, caused a reduction of Tcf12 expression in the sub-ventricular zone (SVZ) and mantle zone (MZ) of the MGE. Mutation of LHX, SOX and octamers, within hs623, caused a reduction of hs623 activity in MGE primary cultures.
Tcf12 expression in the SVZ of the MGE is mediated through aRE hs623. The activity of hs623 is dependent on LHX6, SOX and octamers. Thus, maintaining the expression of Tcf12 in the SVZ involves on TF pathways parallel and genetically downstream of NKX2–1.
KeywordsTCF12 SOX OCT LHX MEIS Medial ganglionic eminence CRISPR engineering Transcriptional network Neurogenesis
activating regulatory element
lateral ganglionic eminence
medial ganglionic eminence
repressing regulatory element
Transcription factors (TFs) direct cell fate determination and differentiation through binding to a genomic network consisting of regulatory elements (REs) such as promoters and enhancers. By analyzing epigenetic modifications and transcriptional changes in TF knockouts, we have started to uncover the genomic networks and molecular mechanisms that direct brain development . In-depth understanding of the genetically encoded wiring of the brain is important as perturbation of transcription pathways is implicated in disorders such as autism and intellectual disability . Distantly acting REs have been identified based on conservation and activity [3, 4]. Their spatial activity and dynamic genomic contacts can be predicted using a combination of TF binding profiling, genome-wide 3D chromosome organization mapping and CRISPR/Cas9 editing [5, 6, 7, 8, 9, 10].
Mouse genetic experiments have elucidated the functions of many TFs in the development of the subpallial telencephalon [11, 12]. These studies show that the HD protein NKX2–1 is required for regional specification of the MGE by repressing alternative identities, as well as promoting GABAergic and cholinergic cell fates via the induction of TFs such as LHX6 and LHX8 [13, 14, 15, 16, 17]. By integrating genomic data with mouse genetics, we confirmed the repressive function of NKX2–1, however its role in transcriptional activation remains unclear. Moreover, additional data suggests that genes genetically downstream of NKX2–1, such as LHX6 and LHX8, are responsible for the loss of gene expression observed in the Nkx2–1cKO [18, 19]. Altogether, the genetic program and molecular mechanisms responsible for promoting GABAergic and cholinergic neuron phenotypes, downstream of NKX2–1 remains largely unexplored.
To investigate the signaling pathways of MGE development downstream of NKX2–1, we extended our earlier analysis of the genomic network directing MGE development that is altered in the Nkx2–1 mutant. First we evaluated all loci that showed an epigenetic change, independent of NKX2–1 binding. Via an epigenomic analysis of the NKX2–1 mutant MGE we characterized a large set REs that are implicated in mediating transcriptional repression and activation. Using a combination of genomics, de novo motif analysis, CRISPR engineering and primary culture assays we characterize REs and TFs central to patterning of the subpallial telencephalon and promoting MGE characteristics. Gene ontology (GO) analysis showed an enriched association of REs activating transcription (aREs) with E-box binding basic-Helix-Loop-Helix (bHLH) TFs. Using CRISPR engineering we deleted hs623, an intronic aRE of the Tcf12 gene which encodes a bHLH TF. Deletion of hs623 reduced Tcf12 expression in the MGE. De novo motif analysis combined with TF motif mutations, showed that OCT/POU and SOX motifs are required for hs623’s ability to promote transcription in the MGE.
The Nkx2–1cKO was earlier described in Sandberg et al. 2016  and generated using mice strains previously reported: Nkx2–1f/f , Olig2-tva-Cre  and AI14 Cre-reporter . All experiments with animals complied with federal and institutional guidelines and were reviewed and approved by the UCSF Institutional Animal Care and Use Committee.
Generation of hs623 deletion
The hs623Tm1 allele was generated by CRISPR-mediated genome editing, using established methods . Guide RNAs sgRNA-hs623–1, 5′-GTTTAGTTTTGCTCATACCA(TGG)-3′ and sgRNA-hs623–2, 5′-ATGGTTTCTGTGATCGTAAT(TGG)-3′ (protospacer-adjacent motif [PAM] sequence indicated in parentheses) were transcribed in vitro using the MEGAshortscript T7 kit (Life Technologies, AM1354) and subsequently purified using the MEGAclear kit (Life Technologies, AM1908). The two guide RNAs were designed to delete a 737 bp intronic region within Tcf12 [mm9; chr9:71822812–71823548]. The purified sgRNAs were co-injected into the cytoplasm of fertilized mouse oocytes with in vitro transcribed Cas9 mRNA using standard transgenic procedures as previously described . F0 transgenic founders were identified by PCR screening using hs623-KO-F, 5′- GTCATTGTTGCTGTTGGCCT -3′ and hs623-KO-R, 5′- CCACCTCACACTAGATTAAGATACA -3′ to identify the hs623 null alleles (KO = 250 bp, WT = 1008 bp) and hs623-WT-F, 5’-GTGGCTGATGATGTGCTCTGA -3′ and hs623-WT-R, 5’-CTCCATCAGGTTCTTGCCCC-3′ to identify the hs623-WT allele (462 bp). Four independent F0 founders were each outcrossed to wild type mice, and F1 offspring were used for subsequent hs623Tm1 intercrosses to generate hs623-null mice. The hs623 mutant strain (CD1-Tcf12em1Jlr/Mmucd) is available at MMRC (www.mmrrc.org/) with the number RRID: MMRRC_044027-UCD.
Immunofluorescence was performed on 16 μm cryosection as previously described . In situ hybridization was performed as previously described . The following primers were used generate the templates used for the in situ probes: Tcf12_F, TCTCGAATGGAAGACCGC; Tcf12_R, CTCCCTCCTGCCAGGTTT.
Dissection of embryos
RT-qPCR and primary culture experiments were performed on E13.5 micro-dissected MGE. All MGE dissections were performed as follows; the dorsal boundary was defined by the sulcus separating lateral ganglionic eminence (LGE) and MGE. The caudal end of the sulcus defined the caudal boundary. Septum was removed.
Gene expression analysis in hs623KO
To assay differential gene expression in the hs623KO RNA was purified using RNEasy Mini (Qiagen) and cDNA was generated using Superscript III® First-Strand Synthesis System for RT-PCR (Invitrogen). RT-qPCR analysis was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems) using SYBR GreenER qPCR SuperMix (Invitrogen, Cat. No. 11760–100). Unpaired t-test was used to test significance in gene expression between hs623WT and hs623KO using SDHA as internal control [27, 28].
Site-directed mutagenesis of TF binding motifs in hs623
hs623-mut-site#2 and 3-F, gatgtgctctgatatgaaaaaagaaaaaaggtagaatgaatag
hs623-mut-site#2 and/or 3-R, atatcagagcacatcatcagccacattc
hs623-mut-site#4 and 5-F, caaacaactcttttttttgaaaaagaggccttatttgc
hs623-mut-site#4 and 5-R, use “hs623-mut-site#4-R” for PCR
hs623-mut-site#4 and 6-F, caactcttttttttgttaatgaggccttaaaaaaatatttattttttcc
hs623-mut-site#4 and 6-R, cattaacaaaaaaaagagttgtttgaataatcac
hs623-mut-site#4,5 and 6-F, caactcttttttttgaaaaagaggccttaaaaaaatatttattttttcc
hs623-mut-site#4, 5 and 6-R, ggcctctttttcaaaaaaaagagttgtttgaataatc
hs623-mut-site#4 and 7-F, gtgattattcccccccctcttttttttgttaatgagg
hs623-mut-site#4 and 7-R, use hs623-mut-site#7-R
Analysis of hs623 activity in MGE primary MGE cultures
MGE tissue was dissected from E13.5 embryos, triturated and plated onto 24-well plates (1 embryo/2wells). Primary cultures were transfected with a total of 500 ng DNA using Lipofectamin 2000 (Thermo Fisher) and cultured in Neurobasal Medium (Thermo Fisher) supplemented with 0.5% Glucose, GlutaMAX (Thermo Fisher Scientific) and B27 (Thermo Fisher Scientific). Luciferase assays were performed 48 h after transfection using Dual Luciferase Reporter Assay System (Promega). Unpaired t-test was used to test significance between the variants of hs623.
ChIP-Seq computational analysis
Differential ChIP-seq analysis was performed as described in Sandberg et al. 2016 . After differential H3K4me1, H3K27ac and H3K27me3 analysis we merged overlapping sites. Only merged sites that were enriched in H3K4me1 relative to the input datasets and for which the difference in enrichment between Nkx2–1 WT and cKO was not significant (for at least one of the sites among the merged sites) were further considered. Of those, merged sites overlapping with blacklisted genomic regions (http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/mm9-mouse/mm9-blacklist.bed.gz) and RepeatMasker annotation (http://hgdownload.cse.ucsc.edu/goldenPath/mm9/database/chr*_rmsk.txt.gz) as well as those exceeding 5000 bp were excluded. We defined aREs based on the following two criteria; 1) more H3K27ac (WT) and no increase in H3K27me3 (WT), H3K27ac (Nkx2–1cKO) and H3K4me1 (Nkx2–1cKO), 2) more H3K27me3 (Nkx2–1cKO) and no increase in H3K27ac (Nkx2–1cKO), H3K4me1 (Nkx2–1cKO) and H3K27me3 (WT). We defined rREs based on the following two criteria; 1) more H3K27ac (Nkx2–1cKO) and no increase in H3K27me3 (Nkx2–1cKO), H3K27ac (WT) and H3K4me1 (WT), 2) more H3K27me3 (WT) and no increase in H3K27ac (WT), H3K4me1 (WT) and H3K27me3 (Nkx2–1cKO).
In vivo analysis of aREs and rREs
To assess the in vivo activity of aREs and rREs we used the data published in the VISTA Enhancer Browser (https://enhancer.lbl.gov/) . All aREs and rREs, overlapping with regions tested in the VISTA Enhancer Browser were scored based on their in vivo activity in cortex, MGE and LGE. For the MGE active elements, we also scored their activity in the ventricular zone (VZ), SVZ and MZ.
De novo motif analysis
Motif analysis was performed using RSAT , identifying overrepresentation and positional bias of words (6 to 7 nucleotides) in the aREs and rREs using an automated Markov model adapted after the analyzed sequence length. Differential analysis of aREs (rREs as control sequence) and rREs (aREs as control sequence) was also performed to identify overrepresented words in the peak sequence.
Identification of the genomic regulatory network directing MGE identity
We have previously shown that the combined binding of NKX2–1 and LHX6 is a predictive indicator of REs that mediate transcriptional activation in the subventricular (SVZ) and mantle zone (MZ) of the MGE in the developing subpallial telencephalon . There is evidence that NKX2–1 generally acts as a repressor in MGE progenitors (in the ventricular zone [VZ]), whereas LHX6, and potentially other TFs and signaling pathways, some of which are genetically downstream of NKX2–1, are important for activating transcription in the SVZ and MZ of the MGE [18, 30]. By studying aREs, we aimed to further explore the molecular mechanisms underlying the transcriptional network directing differentiation of the secondary progenitors in the SVZ. One important difference between this study and our earlier study  is that here we look at all aREs and rREs, independent of NKX2–1 binding.
First we identified aREs and rREs by assessing the genome-wide changes of the two histone marks H3K27ac and H3K27me3 at H3K4me1 positive REs comparing the WT and Nkx2–1cKO MGE . We defined aREs based on the following two criteria; 1) reduced H3K27ac and, 2) increased H3K27me3 in the Nkx2–1cKO. We defined rREs based on the following two criteria; 1) increased H3K27ac and, 2) reduced H3K27me3 in the Nkx2–1cKO (see Methods).
To identify TFs motifs enriched in the aRE and rREs we performed a de novo motif discovery using RSAT . This analysis showed a number of motifs enriched in both aREs and rREs such as SOX motifs, homedomain binding motifs (HOX and POU6f2) and motifs recognized by zinc finger TFs (e.g. SP1 and ZNF384) (Fig. 1d and e). Additional analysis identifying motifs differentially enriched between aREs and rREs showed that aREs have a high frequency of E-boxes (Fig. 1e). Interestingly, we found that rREs are enriched in motifs consistent with the binding site of the TF MEIS2 (Fig. 1d). The Meis2 gene is repressed by NKX2–1, and in turn, its RNA is strongly up-regulated in the MGE of the Nkx2–1cKO . These data suggest that Meis2 is central to activating a genomic network promoting LGE and caudal ganglionic eminence (CGE) characters (through rREs) in the Nkx2–1cKO MGE.
We then examined enrichment of annotation terms among the aREs and rREs candidate target genes using GREAT . Top-ranked GO terms for rREs target genes were associated with WNT signaling (beta-catenin binding and PDZ domain binding), transcriptional regulation (such as RNA polymerase II transcription co-activator activity), and enhancer sequence-specific DNA binding (Fig. 1f). Looking specifically at the associated genes for the rREs containing MEIS2 binding motifs we found several genes (Isl1, Ebf1, Tle4, Zfp503, Efnb1 and Efnb2) with higher expression in the LGE and CGE than the MGE. These findings support the hypothesis that MEIS2 directs LGE and CGE identities. The top-ranked GO terms for aREs target genes were associated with phosphatase activity, E-box binding proteins, L-glutamate transmembrane transporter activity and transmembrane-ephrin receptor activity  (Fig. 1f). Two E-box binding TFs, Tcf4 and Tcf12, which are in the region of a large number of aREs, have reduced MGE SVZ and MZ expression in the Nkx2–1cKO . In combination with the high frequency of E-boxes in aREs, our data suggests that Tcf4 and Tcf12 are components of the genomic network regulating gene expression in secondary progenitors of the MGE that are genetically downstream of NKX2–1.
In vivo characterization of hs623 in the MGE of the forebrain
Motif logic direct region specific transcriptional activity
Hs623 is flanked by two highly conserved regions and the activity of one of the regions (hs357) has been tested in vivo . Similar to hs623, hs357 is active in the spinal cord, but unlike hs623 it is active in the pretectum and it lacks activity in the telencephalon, including the MGE (Fig. 2f and g). Therefore, despite the close proximity of hs623 and hs357, they show differences in regional activity, suggesting that their regional activities are more likely due to differences in their primary nucleic acid sequence rather then their genomic location. Consistent with the lack of MGE activity, hs357 has two NKX2–1 consensus motifs and no LHX6 consensus motifs (Fig. 2b). On the other hand, hs623 has four LHX6 consensus motifs, which could explain its activity in the MGE (Fig. 2h). Even though hs623 has NKX2–1 binding, it contains no NKX2–1 consensus motifs. However, the sequences flanking hs623 do include three NKX2–1 consensus motifs, two within hs357 (Fig. 2b). In agreement with these observations, we detect NKX2–1 binding covering a wide region that incudes both hs623 and hs357.
CRISPR/Cas9 mediated deletion of hs623 in vivo
To functionally test the requirement of hs623 in vivo, we deleted hs623 using CRISPR/Cas9 (see VISTA database; http://enhancer.lbl.gov). A pair of sgRNAs was designed to delete the 734 bp core sequence of hs623, which has NKX2–1 and LHX6 binding (Fig. 2b and h). Microinjection of sgRNAs and Cas9 generated a total of 22 pups. 23% (5 of 22) of the pups carried the desired hs623 deletions and the induced DNA breaks were distributed within 20 bp of the predicted cutting site (5′ and 3′ of hs623, Fig. 2h, Additional file 3). To minimize potential off target effects we outcrossed the F0 transgenic founders to wild-type CD1 mice. Four of five founders were fertile and generated a F1 generation; these animals were intercrossed to generate homozygous F2 hs623KO animals. Hs623KOs in the F2 generation were produced at Mendelian Ratios showing that the enhancer deletion was viable (10[WT]:19[HET]:7[KO], n = 3 litters; χ2 = 0.611; df = 2; p = 0.7367). Due to the overall similarity of the four fertile founders we decided to focus the following analysis on one of the founders (F0: 2458, Fig. 2h).
Deletion of hs623 reduces Tcf12 mRNA levels in the SVZ of MGE
To obtain spatial information about the reduction of Tcf12 within the MGE we compared the distribution of Tcf12 RNA between WT and hs623KO telencephalon at E13.5 using in situ RNA hybridization. Normally, Tcf12 is broadly expressed in the VZ in the pallium and subpallium. In the ganglionic eminences Tcf12 is also expressed in the SVZ and MZ, with a markedly higher expression in the MGE compared to the LGE. On the other hand, in the hs623KO we observed a reduction of Tcf12 expression that appeared to be specific to the SVZ and MZ of the MGE (Fig. 3c and d). This result is consistent with the spatial activity of hs623, which is restricted to the SVZ of the MGE.
Combined activity of POU and SOX TFs are required to maintain gene expression downstream of NKX2–1 in the MGE
Altogether, our experiments show that Tcf12 expression in the SVZ of the MGE is mediated, at least in part, through hs623, a RE that is strongly dependent on its OCT and SOX motifs and partially dependent on its LHX6 motifs. We have previously shown that gene expression in the SVZ of the MGE (including Tcf12) largely depends on NKX2–1 activity . Existing mechanistic data show that NKX2–1 acts as a transcriptional repressor. Therefore, our findings suggest that the loss of Tcf12 expression in the SVZ of the MGE Nkx2–1cKO is not due to the direct regulation of Tcf12 by NKX2–1, but is a secondary effect due to changes in expression and activity of LHX6, LHX8, OCT and SOX TFs.
Technical advancements in genome wide sequencing, chromosome capture and CRISPR/Cas9 technologies are increasing our understanding of genome organization. These data, combined with data showing RE activities in vivo (https://enhancer.lbl.gov/), TF binding and other epigenetic genomic data, and spatial gene expression data (http://www.brain-map.org/, http://www.eurexpress.org/ee/intro.html), are enabling the field to begin elucidating the genomic networks and the molecular mechanisms that direct brain development. Herein we have used many of these approaches to analyze gene expression in the developing mouse MGE. In the context of the Nkx2–1cKO mouse, our analysis of differential (WT vs. cKO) histone ChIP-seq data, and de novo sequence motif analysis, has provided evidence for additional TFs, REs, and signaling pathways that direct MGE development.
In this study, we showed that Tcf12 expression in the SVZ of the MGE is mediated via hs623, an aRE bound by NKX2–1. The activity of hs623 and the expression of Tcf12 depend on NKX2–1 activity, suggesting that NKX2–1 promotes Tcf12 expression in this context. We find no direct evidence showing that NKX2–1 activates Tcf12 transcription via hs623. On the other hand, we show that LHX6, OCT and SOX motives are central to hs623 activity. In fact, hs623 lacks NKX2–1 consensus motifs and its interaction with hs623 can possibly be explained through binding to three flanking regions. Other alternative explanations are that NKX2–1 regulates hs623 through either uncharacterized NKX2–1 motifs or through indirect binding to transcriptional complexes that bind hs623.
We have earlier demonstrated that NKX2–1 represses transcription in the MGE, similar to other NKX HD TFs that specify ventral parts of the developing neural tube [36, 37]. Even at aREs, identified in the Nkx2–1cKO MGE, the NKX2–1 motifs mediate transcriptional repression, as exemplified by the intragenic Tgfb3 RE in Sandberg et al. 2016 . On the other hand, in the case of both the Tgfb3 RE and hs623, LHX6 motifs promote enhancer activity. If NKX2–1 only represses transcription, it is unclear how loci such as LHX6 and LHX8 fail to be activated in the Nkx2–1 mutants [16, 17, 18]. Furthermore it is unclear why NKX2–1 also binds loci that have reduced activity in the Nkx2–1cKO. These results suggest that, in some contexts, NKX2–1 may have an activating function. NKX2–1 binding to these loci might be required to keep them poised for subsequent activation by TFs and signaling pathways parallel and genetically downstream of NKX2–1, such as LHX, OCT, SOX and bHLH TFs. A similar model was presented in two studies looking at motor neuron development. In these cells, combinations of NEUROG2 (bHLH TF), LHX3, ISL-1, ONECUT1 and EBF direct the progression of the motor neuron fate through distinct sets of REs [8, 9]. Similar to these models, we find an enrichment of LHX6 binding and e-boxes at aREs, a group of REs with a preferential activity in the SVZ of the MGE. This combination of TF binding and motif enrichment is not seen at NKX2–1 bound rREs, that have a relatively low MGE activity. These data highlight similarities in the molecular mechanisms that direct MGE and motor neuron development over time. In addition to combinatorial activity with other TFs, the activity of NKX2–1 might be affected by changes to chromatin modifications at specific loci over time. Our experimental design lacks the temporal resolution to make these kinds of predictions. For the future, it would be interesting to know; 1) at what time point in the developing MGE (VZ, SVZ or MZ) are the various REs active, 2) and the temporal pattern of TF binding at these REs. This would give us important information that could help elucidate the activating and repressing mechanics through which NKX2–1, LHX6 and other TFs direct MGE development.
The seemingly dual activity of NKX2–1 in the MGE is similar to its double-edged characteristics in regulating cancer development and progression. In this context, NKX2–1 has a role as lineage-survival oncogene in developing lung cancer tumors. On the other hand, NKX2–1 expression is also associated with a favorable prognosis in affected patients, due to its capacity to attenuate the invasive capacity of carcinomas . Interestingly, this has been shown to be mediated through an abrogation of cellular response to TGFβ induced EMT, a signaling pathway that is directly repressed by NKX2–1 in the MGE [18, 39]. By identifying the mechanisms through which NKX2–1 operate in the subpallial telencephalon we might also learn more about its enigmatic role in tumor biology.
The activity of the RE hs623 depends on two octamers, providing evidence that OCT TFs are central to MGE development. OCT TFs are important regulators of stem cell maintenance and the progression of neurogenesis. OCT4 is central for propagating undifferentiated embryonic stem cells and has the ability to induce pluripotent stem cells from embryonic and adult fibroblasts [40, 41]. On the contrary, BRN2, together with Ascl1 and Myt1l, can efficiently trans-differentiate embryonic and postnatal fibroblasts into functional neurons . BRN1, BRN2 and OCT6 mutants show defects in layering of the neocortex, due to their role in initiating radial migration of cortical projection neurons, further highlighting their role in promoting neurogenesis [43, 44, 45]. Furthermore, we find an enrichment of both octamers and E-boxes in REs promoting gene expression in the MGE, suggesting that the TF machinery directing trans-differentiation of fibroblasts into neurons is similar to the TF machinery inducing neuronal phenotypes in the MGE. Trans-differentiating fibroblast to neurons using Brn2, Ascl1 and Myt1l generate cells with a mixed neuronal phenotype , indicating that these TFs are required for promoting the neuronal fate, without any preference for specific neuronal lineages. Taken together, this suggests a model where neuronal fate and phenotype is directed through separate, although integrated, TF pathways in the MGE.
One of the octamers in hs623 is paired with a SOX motif. The SOX TF family consists of a large number of genes that direct embryonic development and cell differentiation. They bind loosely to the minor groove of the DNA and their target gene specificity is guided through the interaction with cell type specific partner factors such as OCT TFs. The combined activity of SOX2 and different OCT TFs are important regulators of gene expression in undifferentiated embryonic stem cells (ESCs) and neural progenitor cells (NPCs) . SOX2 and OCT4 (POU5F1) bind REs in ECSs, whereas SOX2 and BRN2 (POU3F2) co-occupy REs in NPCs [34, 46, 47, 48]. SOX and OCT motifs have also been shown to direct transcription in both ESCs and NPCs in the forebrain [34, 35]. Today we do not know what specific OCT and SOX TFs that are required to activate transcription in the SVZ of the MGE, via REs like hs623, BRN1 (POU3F3), BRN2 (POU3F2), BRN4 (POU3F4), BRN5 (POU6F1) and OCT6 (POU3F1) are all expressed here, but little is know regarding their function in this context. A large number of different SOX TFs are expressed in the MGE and several of them show a reduced expression in the Nkx2–1cKO, such as Sox1, Sox2, Sox6, Sox11 and Sox21 constituting possible candidates for promoting Tcf12 expression via hs623. Sox6 is required for patterning of the subpallium and generation on MGE derived interneurons [49, 50], but when looking at Tcf12 expression in the E13.5 MGE of a conditional Sox6 mouse  with an Nkx2–1-Cre line , we found no significant change in Tcf12 expression (Additional file 4). From this we can suggest that SOX6 is not sufficient for promoting Tcf12 expression. Further studies should be performed to identify the specific OCT and SOX TFs directing transcriptional activation in the MGE.
Here, in our new analysis of the Nkx2–1cKO, we found a large number aREs. Some of these are near the loci of the Tcf4 and Tcf12 bHLH TF encoding genes. The Nkx2–1cKO shows a near complete loss of Tcf12 expression in the SVZ and MZ of the MGE. We found an aRE intronic to Tcf12 (hs623) that has activity in the SVZ and MZ of the MGE (Fig. 2e). Deletion of hs623 leads to a reduced Tcf12 expression in the VZ and MZ of the MGE. This result suggests that Tcf12 expression is regulated through several aREs, including hs623, and that there is redundancy between these REs. Enhancer redundancy has been demonstrated in the developing telencephalon and limb where REs sharing a similar spatiotemporal activity provides robustness to gene expression [53, 54]. We also find that there are different genetic programs directing Tcf12 expression in various cell types of the MGE. Tcf12 expression is initiated in the VZ of the MGE; this expression is largely unaffected in the Nkx2–1cKO, indicating that Tcf12 expression in this region is not mediated through hs623 and largely NKX2–1 independent.
Altogether, these data provide evidence of transcriptional circuitry that connects the initiation of MGE fate in the VZ by Nkx2–1 and Otx2, to the maturation of cells in the SVZ and MZ by driven through REs such as hs632, whose activity integrates signals from LHX, OCT, SOX and bHLH TFs [16, 18, 55]. Future studies will investigate how TFs, chromatin-binding, −reading and -remodeling proteins integrate to direct GABAergic and cholinergic development in the subpallial telencephalon.
In our study we use a combination of genomics, CRISPR/Cas9 engineering and TF motif analysis to investigate the transcriptional networks guiding development of the MGE and its descendants. Whereas NKX2–1 is required for initiating MGE characteristics in the VZ, we provide evidence that a combination of LHX, OCT, SOX and bHLH TFs are central for maintaining gene expression in the SVZ and MZ, genetically down-stream of NKX2–1. Here we generate a mouse mutant in whom we delete a Tcf12 intragenic RE, showing its requirement for maintaining Tcf12 transcription in the SVZ and MZ of the MGE. The activity of this Tcf12 enhancer, in primary cultures of MGE cells, largely depends on an octamer and a combined octamer and SOX motif. Altogether, our study identifies a genomic framework through which a combination of LHX, OCT, SOX and bHLH TFs direct MGE differentiation through the expression terminal effector genes.
We thank members of the Rubenstein, Taher, Black and Nord laboratories for advice and critical evaluation of the data during the course of the study.
This project was supported by Vetenskapsrådet 2011–38865–83000-30 (M.S.), Svenska Sällskapet för Medicinsk Forskning (M.S.), NIMH R01 MH081880 (J.L.R.R.), NIH R01s HL064658 (B.L.B.) and HL136182 (B.L.B.)
Availability of data and materials
The datasets supporting the conclusions of this article are available in the NCBI’s GEO repository, GEO Series accession number GSE85705 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85705 acc.cgi?acc = GSE85705). Additional material is available from the corresponding author upon request.
MS, JLRR and AN conceived the experiments, interpreted the results, wrote, reviewed and edited the manuscript. MS designed and performed all experiments. JH and BB injected sgRNA and Cas9 to generate hs623KO mice. LT performed the differential ChIP-seq enrichment analysis. All authors read and approved the final manuscript.
Ethics approval and consent to participate
All animal procedures were performed following protocols (AN143392-02B [J.L.R.R.] and AN171299–01 [B.L.B.]) authorized by the University of California San Francisco Institutional Animal Care and Use Committee (IACUC).
Consent for publication
J.L.R.R. is cofounder, stockholder, and currently on the scientific board of Neurona, a company studying the potential therapeutic use of interneuron transplantation.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 1.Nord AS, Pattabiraman K, Visel A, Rubenstein JLR. Genomic perspectives of transcriptional regulation in forebrain development. Neuron Elsevier Inc. 2015;85:27–47.Google Scholar
- 2.De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. 2014.Google Scholar
- 3.Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature. Nature Publishing Group. 2006;444:499–502.Google Scholar
- 4.Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nat Publ Group. 2009;457:854–8.Google Scholar
- 5.Zinzen RP, Girardot C, Gagneur J, Braun M, Furlong EEM. Combinatorial binding predicts spatio-temporal cis-regulatory activity. Nat Publ Group. 2009;462:65–70.Google Scholar
- 6.Bonev B, Cohen NM, Szabo Q, Fritsch L, Papadopoulos GL, Lubling Y, et al. Multiscale 3D Genome Rewiring during Mouse Neural Development. Cell. Elsevier. 2017;171:557–572.e24.Google Scholar
- 12.Rubenstein JLR, Campbell K. Neurogenesis in the Basal Ganglia. Patterning and Cell Type Specification in the Developing CNS and PNS. Elsevier. 2013:455–73.Google Scholar
- 16.Sussel L, Marin O, Kimura S, Rubenstein JL. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development. 1999;Google Scholar
- 28.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods Academic Press. 2001;25:402–8.Google Scholar
- 39.Saito R-A, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, et al. Thyroid Transcription Factor-1 Inhibits Transforming Growth Factor-β–Mediated Epithelial-to-Mesenchymal Transition in Lung Adenocarcinoma Cells. Cancer Res. Am Assoc Cancer Res. 2009;69:2783–91.Google Scholar
- 44.Sugitani Y, Nakai S, Minowa O, Nishi M, Jishage K-I, Kawano H, et al. Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. Genes & Development Cold Spring Harbor Lab. 2002;16:1760–5.Google Scholar
- 46.Lodato MA, Ng CW, Wamstad JA, Cheng AW, Thai KK, Fraenkel E, et al. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. Barsh GS, editor. PLoS Genet. Public Libr Sci; 2013;9:e1003288.Google Scholar
- 47.Ambrosetti DC, Basilico C, Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol. Am Soc Microbiol. 1997;17:6321–9.CrossRefGoogle Scholar
- 53.Osterwalder M, Barozzi I, Tissières V, Fukuda-Yuzawa Y, Mannion BJ, Afzal SY, et al. Enhancer redundancy provides phenotypic robustness in mammalian development. Nature. Nat Publ Group. 2018;489:57.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.